Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database
Most of the adverse reaction findings in this study are consistent with previous clinical research, and we have also identified new potential AEs associated with sulfasalazine. These findings provide valuable insights for the safety monitoring and clinical application of sulfasalazine.
Authors
- Wangyu Ye
- Zhen Liu (ORCID: https://orcid.org/0000-0002-8440-2554)
- Shaoli Wang (ORCID: https://orcid.org/0000-0002-6675-0950)
- Meng Li (ORCID: https://orcid.org/0000-0001-8399-8483)
- Yuan Ding
- Zhihua Tian
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Guang’anmen Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-12
- DOI
- https://doi.org/10.3389/fphar.2024.1452300
- Citations
- 19
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 6.66